CoChat

A systemic evaluation of the effect of dsRNA contamination on mRNA vaccine expression and immunogenicity

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

Double-stranded RNA (dsRNA) contamination generated during in vitro transcription (IVT) poses a significant challenge to the efficacy and safety of messenger RNA (mRNA) vaccines. This study systematically examined how varying dsRNA levels influence mRNA translation and immunogenicity using influenza hemagglutinin (HA) and human papillomavirus (HPV) E7 antigens as model systems, representing preventive and therapeutic vaccine targets, respectively. IVT-produced mRNA was synthesized using either uridine or N1-methyl-pseudouridine (m1Ψ) nucleosides, purified by cellulose chromatography, and supplemented with increasing synthetic dsRNA concentrations. In vivo experiments in mice revealed that high dsRNA concentrations markedly decreased antigen expression and increased pro-inflammatory cytokine production, regardless of nucleoside modification. Preventive HA mRNA vaccines containing elevated dsRNA levels showed decreased antibody titers and impaired T-cell responses. Conversely, therapeutic HPV E7 mRNA vaccines showed antigen-dependent variability; moderate dsRNA levels enhanced CD8+ T-cell responses, whereas higher concentrations were suppressive. Structural analysis of the RNA indicated that the HPV construct, with higher UTP content and reduced thermodynamic stability, generated more dsRNA during IVT, contributing to the observed immunostimulatory effects. Our findings indicate that dsRNA impurities act as a double-edged sword: low levels can function as beneficial immune adjuvants, whereas excessive amounts significantly hinder antigen expression and adaptive immunity. These results underscore the need for optimized dsRNA purification strategies tailored to specific antigens to balance immunogenicity and vaccine safety effectively. This study provides essential insights into refining mRNA vaccine production, highlighting the necessity of stringent control over dsRNA levels to maximize both preventive and therapeutic vaccine efficacy and minimize unintended inflammation.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2025.114471

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Cited by

See all 14

Metadata

Authors
Jo, S., Lee, J., Park, S.-I., Kim, Y., Yoon, S., Lee, S., Cho, S., Cho, Y., Oh, A., Ha, D., Choi, H., Kim, J., Lee, Y., Lee, S., Lee, S.-Y., Choi, E.-J., Roh, G., Lee, Y.-S., Bae, S.-H., Jeon, S., Park, H.-J., & Nam, J.-H.
Affiliations
  • Catholic University of Korea (KR)
  • Daegu Haany University (KR)
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2026-01
Volume
389
Pages
114471
ISSN
0168-3659 (ISSN-L)
OpenAlex
W4416764636
Cited by
14
References
36
Citations by year
2026: 14
FWCI
2.72
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Controlled Release (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Korea Ministry of Health and Welfare (RS-2024-00507060)
  • Korea Health Industry Development Institute
  • Korea Ministry of Food and Drug Safety (22213MFDS421, RS-2025-02213409)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
Keywords
mRNA vaccines, in vitro transcription, uridine nucleosides, influenza hemagglutinin, E7 oncoprotein, mRNA translation, immunogenicity, inflammatory cytokines, CD8+ T cell responses, vaccine adjuvants
MeSH terms
Immunogenicity, Vaccine, mRNA Vaccines, Animals, Drug Contamination, Female, Humans, Mice, Inbred C57BL, RNA, Double-Stranded, RNA, Messenger, CD8-Positive T-Lymphocytes, Hemagglutinin Glycoproteins, Influenza Virus, Papillomavirus E7 Proteins, Mice, Papillomavirus Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.